Articles dans des revues avec comité de lecture (78)
  1. 1. Bouhtit, F., Najar, M., Rahmani, S., Melki, R., Najimi, M., Sadki, K., Boukhatem, N., Twizere, J.-C., Meuleman, N., Lewalle, P., Lagneaux, L., & Merimi, M. (2022). Bioscreening and pre-clinical evaluation of the impact of bioactive molecules from Ptychotis verticillata on the multilineage potential of mesenchymal stromal cells towards immune- and inflammation-mediated diseases. Inflammation research, 71(7-8), 887-898. doi:10.1007/s00011-022-01573-3
  2. 2. Andreozzi, F., Massaro, F., Wittnebel, S., Spilleboudt, C., Lewalle, P., & Salaroli, A. (2022). New Perspectives in Treating Acute Myeloid Leukemia: Driving towards a Patient-Tailored Strategy. International journal of molecular sciences, 23(7), 3887. doi:10.3390/ijms23073887
  3. 3. Najar, M., Melki, R., Khalife, F., Lagneaux, L., Bouhtit, F., Moussa Agha, D., Fahmi, H., Lewalle, P., Fayyad Kazan, M., & Merimi, M. (2022). Therapeutic Mesenchymal Stem/Stromal Cells: Value, Challenges and Optimization. Frontiers in Cell and Developmental Biology, 9, 716853. doi:10.3389/fcell.2021.716853
  4. 4. Otmani, K., & Lewalle, P. (2021). Tumor Suppressor miRNA in Cancer Cells and the Tumor Microenvironment: Mechanism of Deregulation and Clinical Implications. Frontiers in oncology, 11, 708765. doi:10.3389/fonc.2021.708765
  5. 5. Merimi, M., El-Majzoub, R., Lagneaux, L., Moussa Agha, D., Bouhtit, F., Meuleman, N., Fahmi, H., Lewalle, P., Fayyad Kazan, M., & Najar, M. (2021). The Therapeutic Potential of Mesenchymal Stromal Cells for Regenerative Medicine: Current Knowledge and Future Understandings. Frontiers in Cell and Developmental Biology, 9. doi:10.3389/fcell.2021.661532
  6. 6. Berehab, M., Rouas, R., Akl, H., Duvillier, H., Journé, F., Fayyad Kazan, H., Ghanem, G. E., Bron, D., Lewalle, P., & Merimi, M. (2021). Apoptotic and non-apoptotic modalities of thymoquinone-induced lymphoma cell death: Highlight of the role of cytosolic calcium and necroptosis. Cancers (Basel), 13(14), 3579. doi:10.3390/cancers13143579
  7. 7. Merimi, M., Buyl, K., Daassi, D., Rodrigues, R. M., Melki, R., Lewalle, P., Vanhaecke, T., Fahmi, H., Rogiers, V., Lagneaux, L., De Kock, J., & Najar, M. (2021). Transcriptional profile of cytokines, regulatory mediators and tlr in mesenchymal stromal cells after inflammatory signaling and cell-passaging. International journal of molecular sciences, 22(14), 7309. doi:10.3390/ijms22147309
  8. 8. Merimi, M., Lewalle, P., Meuleman, N., Agha, D. M., El-Kehdy, H., Bouhtit, F., Ayoub, S., Burny, A., Fahmi, H., Lagneaux, L., & Najar, M. (2021). Mesenchymal Stem/Stromal Cell Therapeutic Features: The Bridge between the Bench and the Clinic. Journal of Clinical Medicine, 10(5). doi:10.3390/jcm10050905
  9. 9. Spilleboudt, C., De Wilde, V., Lewalle, P., Cabanne, L., Leclerc, M., Beckerich, F., Bories, D., Cardoso, S., Soares, M. P., Vokaer, B., Hougardy, J.-M., Flamand, V., Racapé, J., Abramowicz, M., Maury, S., & Le Moine, A. (2021). Donor-Derived Myeloid Heme Oxygenase-1 Controls the Development of Graft-Versus-Host Disease. Frontiers in immunology, 11, 579151. doi:10.3389/fimmu.2020.579151
  10. 10. Merimi, M., Lagneaux, L., Lombard, C. A., Moussa Agha, D., Bron, D., Lewalle, P., Meuleman, N., Najimi, M., Sokal, E. M., & Najar, M. (2021). Immuno-comparative screening of adult-derived human liver stem/progenitor cells for immune-inflammatory-associated molecules. Inflammation research. doi:10.1007/s00011-020-01428-9
  11. 11. Bouhtit, F., Najar, M., Moussa Agha, D., Melki, R., Najimi, M., Sadki, K., Boukhatem, N., Bron, D., Meuleman, N., Hamal, A., Lagneaux, L., Lewalle, P., & Merimi, M. (2021). New Anti-Leukemic Effect of Carvacrol and Thymol Combination through Synergistic Induction of Different Cell Death Pathways. Molecules (Print Archive Edition), 26(2), 410. doi:10.3390/molecules26020410
  12. 12. Devos, T., Havelange, V., Theunissen, K., Meers, S., Benghiat, F., Gadisseur, A. P. A. A., Vanstraelen, G., Vellemans, H., Bailly, B., Granacher, N., Lewalle, P., De Becker, A., Van Eygen, K., Janssen, M., Triffet, A., Vrelust, I., Deeren, D., Mazure, D., Bekaert, J., Beck, M., & Selleslag, D. (2021). Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice—data from a Belgian registry. Annals of hematology. doi:10.1007/s00277-021-04507-x
    13. << Précédent 1 2 3 4 5 6 7 Suivant >>